Something evil this way comes: Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation

J Heart Lung Transplant. 2022 Mar;41(3):269-270. doi: 10.1016/j.healun.2021.12.003. Epub 2021 Dec 16.

Authors

Hakim Uqdah¹, Shelley Hankins¹, Howard J Eisen²

Affiliations

¹ Heart and Vascular Institute, Pennsylvania State University College of Medicine/Milton S. Hershey Medical Center, Hershey, Pennsylvania.
² Heart and Vascular Institute, Pennsylvania State University College of Medicine/Milton S. Hershey Medical Center, Hershey, Pennsylvania. Electronic address: heisen@pennstatehealth.psu.edu.

PMID: 35177247
DOI: 10.1016/j.healun.2021.12.003

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biomarkers
Heart Transplantation* / adverse effects
Humans
Lectins, C-Type
Membrane Glycoproteins
Primary Graft Dysfunction* / diagnosis
Proteomics
Receptors, Immunologic

Substances

Biomarkers
CLEC4C protein, human
Lectins, C-Type
Membrane Glycoproteins
Receptors, Immunologic